| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-09 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-08 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-08 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |